ARK Genomic Revolution ETF (ARKG)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn morePerformance Overview
Trailing returns as of 10/29/2026. Category is Health.
YTD Return
1-Year Return
3-Year Return
Trailing Returns (%) Vs. Benchmarks
- YTD
- 87.49%
- -2.39%
- 1-Month
- 14.80%
- 1.70%
- 3-Month
- 28.92%
- -3.03%
- 1-Year
- 95.19%
- 21.31%
- 3-Year
- 24.92%
- 6.58%
- 5-Year
- -6.08%
- 1.49%
- 10-Year
- 11.42%
- 8.56%
- Last Bull Market
- 0.00%
- 0.00%
- Last Bear Market
- 0.00%
- 0.00%
Annual Total Return (%) History
ETF Summary
The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified.
ETF Overview
| Category | Health |
|---|---|
| Fund Family | ARK ETF Trust |
| Net Assets | 2.22B |
| YTD Daily Total Return | 90.23% |
| Yield | 0.00% |
| Legal Type | Exchange Traded Fund |
